Found: 14
Select item for more details and to access through your institution.
Heme Oxygenase‐1 Overexpression Activates the IRF1/DRP1 Signaling Pathway to Promote M2‐Type Polarization of Spinal Cord Microglia.
- Published in:
- Drug Development Research, 2024, v. 85, n. 8, p. 1, doi. 10.1002/ddr.70033
- By:
- Publication type:
- Article
Lifitegrast, a Lymphocyte Function‐Associated Antigen‐1 Antagonist Demonstrates Beneficial Effect in Psoriasis.
- Published in:
- Drug Development Research, 2024, v. 85, n. 8, p. 1, doi. 10.1002/ddr.70034
- By:
- Publication type:
- Article
AEBP1 Silencing Protects Against Cerebral Ischemia/Reperfusion Injury by Regulating Neuron Ferroptosis and Microglia M2 Polarization Through PRKCA‐PI3K‐Akt Axis.
- Published in:
- Drug Development Research, 2024, v. 85, n. 8, p. 1, doi. 10.1002/ddr.70032
- By:
- Publication type:
- Article
Design and Discovery of New Dual Carbonic Anhydrase IX and VEGFR‐2 Inhibitors Based on the Benzenesulfonamide‐Bearing 4‐Thiazolidinones/2,4‐Thiazolidinediones Scaffold.
- Published in:
- Drug Development Research, 2024, v. 85, n. 8, p. 1, doi. 10.1002/ddr.70030
- By:
- Publication type:
- Article
Fluorinated Sulfonamides: Synthesis, Characterization, In Silico, Molecular Docking, ADME, DFT Predictions, and Structure‐Activity Relationships, as Well as Assessments of Antimicrobial and Antioxidant Activities.
- Published in:
- Drug Development Research, 2024, v. 85, n. 8, p. 1, doi. 10.1002/ddr.70029
- By:
- Publication type:
- Article
Anxiolytic Effect of Sesamol, Possibly Through the GABAkine Interaction Pathway.
- Published in:
- Drug Development Research, 2024, v. 85, n. 8, p. 1, doi. 10.1002/ddr.70028
- By:
- Publication type:
- Article
Research Progress of Endoplasmic Reticulum Targeting Metal Complexes in Cancer Therapy.
- Published in:
- Drug Development Research, 2024, v. 85, n. 8, p. 1, doi. 10.1002/ddr.70027
- By:
- Publication type:
- Article
Does Metabolic Manager Show Encouraging Outcomes in Alzheimer's?: Challenges and Opportunity for Protein Tyrosine Phosphatase 1b Inhibitors.
- Published in:
- Drug Development Research, 2024, v. 85, n. 8, p. 1, doi. 10.1002/ddr.70026
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Drug Development Research, 2024, v. 85, n. 8, p. 1, doi. 10.1002/ddr.70024
- Publication type:
- Article
Improving the Biopharmaceutical Properties of Cannabinoids in Glioblastoma Multiforme Therapy With Nanotechnology: A Drug Delivery Perspective.
- Published in:
- Drug Development Research, 2024, v. 85, n. 8, p. 1, doi. 10.1002/ddr.70023
- By:
- Publication type:
- Article
Design, Synthesis, and Biological Activities Evaluation of Type I FLT3 Inhibitors for the Treatment of Acute Myeloid Leukemia.
- Published in:
- Drug Development Research, 2024, v. 85, n. 8, p. 1, doi. 10.1002/ddr.70022
- By:
- Publication type:
- Article
Unveiling Immunotherapy Evasion in Lung Cancer: The Role of Fanconi Anemia and Stemness Genes in Shaping an Immunosuppressive Microenvironment.
- Published in:
- Drug Development Research, 2024, v. 85, n. 8, p. 1, doi. 10.1002/ddr.70020
- By:
- Publication type:
- Article
Formulation and Characterization of RBCS Coated Carboplatin Loaded Nano‐Liposomal Formulation for Managing Breast Cancer.
- Published in:
- Drug Development Research, 2024, v. 85, n. 8, p. 1, doi. 10.1002/ddr.70019
- By:
- Publication type:
- Article
New Dichalcogenides Induce Oxidative Stress and Cell Death of Leishmania amazonensis.
- Published in:
- Drug Development Research, 2024, v. 85, n. 8, p. 1, doi. 10.1002/ddr.70018
- By:
- Publication type:
- Article